相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 询价记录
- 文献和实验
- 技术资料
- 保存条件:
-20℃
- 保质期:
1年
- 英文名:
Triptolide
- 库存:
999
- 供应商:
仕诺达生物
- CAS号:
38748-32-2
- 规格:
20mg,分析标准品,HPLC≥98%(多种规格可选)/100mg,分析标准品,HPLC≥98%
| 规格: | 20mg,分析标准品,HPLC≥98%(多种规格可选) | 产品价格: | ¥750.0 |
|---|---|---|---|
| 规格: | 100mg,分析标准品,HPLC≥98% | 产品价格: | ¥2000.0 |

核磁图谱:

■针对客户购买情况公司有不同的优惠折扣,欢迎咨询订购~
■郑重申明:本公司销售所有产品均为实物拍摄,如产品出现质量问题,本公司包一切售后!!!
■500元以上包邮,本公司提供正规发票,货到付款,可按科研实验要求定制产品!!!
■本公司已与很多高校中科院及研发单位合作并也获得了老师的认可和推荐!!!

风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
- 作者
- 内容
- 询问日期
文献和实验该产品被引用文献
- 61. [6.9] Liuchunyang Yu et al."Application of galactosylated albumin for targeted delivery of triptolide to suppress hepatocellular carcinoma progression through inhibiting de novo lipogenesis."BIOMEDICINE & PHARMACOTHERAPY.2024 Oct;179:117432
- 60. [14.7] Lai Wang et al."A rationally designed CD19 monoclonal antibody-triptolide conjugate for the treatment of systemic lupus erythematosus."Acta Pharmaceutica Sinica B.2024 Sep;:
- 59. [4.8] Li Qiang et al."Novel Detoxifier of Spironolactone Against Triptolide-induced Hepatotoxicity through Inhibition of RPB1 Degradation."JOURNAL OF ETHNOPHARMACOLOGY.2024 Aug;:118722
- 58. [6.5] Zhe Li et al."Homotypic cell membrane-camouflaged biomimetic PLGA nanoparticle loading triptolide for the treatment of hepatocellular carcinoma."DRUG DELIVERY.
- 57. [IF=6.1] Qiao-Lei Wang et al."Ultrasensitive upconverting nanoprobes for in situ imaging of drug-induced liver injury using miR-122 as the biomarker."TALANTA".2024 Jul;274:126108
- 56. [IF=2.9] Hanping Liang et al."Triptolide inhibits esophageal squamous cell carcinoma progression by regulating the circNOX4/miR-153-3p/SATB1 signaling pathway."Thoracic Cancer.2024 Jan;:
- 55. [IF=5.6] Shiyuan Jiang et al."Triptolide attenuates CCL4-induced liver fibrosis by regulating the differentiation of CD4+ T cells in mice."INTERNATIONAL IMMUNOPHARMACOLOGY.2023 Dec;125:111206
- 54. [IF=5.1] Wang Qian et al."HSP90 Exacerbates Bone Destruction in Rheumatoid Arthritis by Activating TRAF6/NFATc1 Signaling."INFLAMMATION.2023 Oct;:1-13
- 53. [IF=3.3] Wan Lei et al."A novel pharmaceutical preparation of Tripterygium wilfordii Hook. f. regulates macrophage polarization to alleviate inflammation in rheumatoid arthritis."JOURNAL OF PHARMACY AND PHARMACOLOGY.10.1093/jpp/rgad078
- 52. [IF=7.9] Zhiyan Qin et al."Mitigation of triptolide-induced testicular Sertoli cell damage by melatonin via regulating the crosstalk between SIRT1 and NRF2."PHYTOMEDICINE.2023 Sep;118:154945
- 51. [3.222] Chenlei Lv et al."Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway."RENAL FAILURE.2023;45(1):Article: 2165103
- 50. [9.417] Yunan Zhao et al."Engineering adipocytes for targeting delivery of triptolide derivative and Ce6 for malignant melanoma cytotoxic-PDT synergistic strategy."MATERIALS & DESIGN.2023 Apr;228:111860
- 49. [2.626] Ma, Rui-jiao et al."Kunxian Capsule Extract Inhibits Angiogenesis in Zebrafish Embryos via PI3K/AKT-MAPK-VEGF Pathway."Chinese Journal of Integrative Medicine.2022 Dec;:1-9
- 48. [IF=3.685] Guoyao Tan et al."MitoQ alleviates triptolide-induced cardiotoxicity via activation of p62/Nrf2 axis in H9c2 cells."TOXICOLOGY IN VITRO.2023 Feb;86:105487
- 47. [IF=5.195] Yanqiu Sun et al."Xinfeng capsule inhibits inflammation and oxidative stress in rheumatoid arthritis by up-regulating LINC00638 and activating Nrf2/HO-1 pathway."JOURNAL OF ETHNOPHARMACOLOGY.2023 Jan;301:115839
- 46. [IF=2.984] Linluo Zhang et al."Protection of catalpol against triptolide-induced hepatotoxicity by inhibiting excessive autophagy via the PERK-ATF4-CHOP pathway."Peerj. 2022 Jan;10:e12759
- 45. [IF=10.435] Li Zhe et al.Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma.J Nanobiotechnol. 2021 Dec;19(1):1-12
- 44. [IF=3.411] Zhou Yuyan et al."Arctiin Antagonizes Triptolide-Induced Hepatotoxicity via Activation of Nrf2 Pathway."Biomed Res Int. 2020;2020:2508952
- 43. [IF=4.617] Li Zhe et al."γ-Cyclodextrin metal–organic framework as a carrier to deliver triptolide for the treatment of hepatocellular carcinoma."Drug Delivery and Translational Research. 2021 Apr 15
- 42. [IF=5.914] Bo Ma et al."Luteolin Ameliorates Testis Injury and Blood–Testis Barrier Disruption through the Nrf2 Signaling Pathway and by Upregulating Cx43."Mol Nutr Food Res. 2019 May;63(10):1800843
- 41. [IF=6.419] Yanwen Zheng et al."Membrane protein-chimeric liposome-mediated delivery of triptolide for targeted hepatocellular carcinoma therapy."Drug Deliv. 2021;28(1):2033-2043
- 40. [IF=6.684] Yi-Sheng Song et al."Validation, Optimization, and Application of the Zebrafish Developmental Toxicity Assay for Pharmaceuticals Under the ICH S5(R3) Guideline."Front Cell Dev Biol. 2021; 9: 721130
- 39. [IF=9.229] Liangdi Jiang et al."Engineering Exosomes Endowed with Targeted Delivery of Triptolide for Malignant Melanoma Therapy."Acs Appl Mater Inter. 2021;13(36):42411–42428
- 38. [IF=2.303] Ingrid Elisia et al."Comparison of RAW264.7, human whole blood and PBMC assays to screen for immunomodulators."J Immunol Methods. 2018 Jan;452:26
- 37. [IF=3.347] Jiamin Kong et al."Triptolide induces mitochondria-mediated apoptosis of Burkitt's lymphoma cell via deacetylation of GSK-3β by increased SIRT3 expression."Toxicol Appl Pharm. 2018 Mar;342:1
- 36. [IF=3.585] Jie Zhang et al."MitoQ ameliorates testis injury from oxidative attack by repairing mitochondria and promoting the Keap1-Nrf2 pathway."Toxicol Appl Pharm. 2019 May;370:78
- 35. [IF=5.875] Yongwei Gu et al."Transdermal drug delivery of triptolide-loaded nanostructured lipid carriers: Preparation, pharmacokinetic, and evaluation for rheumatoid arthritis."Int J Pharmaceut. 2019 Jan;554:235
- 34. [IF=6.4] Li Zhang et al."Fabrication of a triptolide-loaded and poly-γ-glutamic acid-based amphiphilic nanoparticle for the treatment of rheumatoid arthritis."Int J Nanomed. 2018; 13: 2051–2064
- 33. [IF=10.435] Yang Meng et al."Development of triptolide-nanoemulsion gels for percutaneous administration: physicochemical, transport, pharmacokinetic and pharmacodynamic characteristics."J Nanobiotechnol. 2017 Dec;15(1):1-15
- 32. [IF=10.435] Gu Yongwei et al."Lipid nanoparticles loading triptolide for transdermal delivery: mechanisms of penetration enhancement and transport properties."J Nanobiotechnol. 2018 Dec;16(1):1-14
- 31. Elisia, Ingrid, et al. "Comparison of RAW264. 7, human whole blood and PBMC assays to screen for immunomodulators." Journal of immunological methods 452 (2018): 26-31.
- 30. Shan, Qian-Qian, et al. "Cubic and hexagonal liquid crystals as drug carriers for the transdermal delivery of triptolide." Drug delivery 26.1 (2019): 490-498.
- 29. Yang, Meng, et al. "Development of triptolide-nanoemulsion gels for percutaneous administration: physicochemical, transport, pharmacokinetic and pharmacodynamic characteristics." Journal of nanobiotechnology 15.1 (2017): 1-15.
- 28. Zhang, Jie, et al. "MitoQ ameliorates testis injury from oxidative attack by repairing mitochondria and promoting the Keap1-Nrf2 pathway." Toxicology and applied pharmacology 370 (2019): 78-92.
- 27. 汪五清,贺燕妮,曾义斌,张彤,朱瑞政,左付国.雷公藤甲素固体脂质纳米粒的制备及其抗慢性皮炎湿疹的作用研究[J].上海医药,2021,42(01):14-18+31.
- 26. 周玉燕,陆萧雅,夏丽,姚伟强,秦国正,王国栋.牛蒡子苷通过抑制炎症通路降低雷公藤甲素所致肾毒性[J].南方医科大学学报,2020,40(10):1399-1405.
- 25. 曾晶,朱龙.响应曲面法优化雷公藤甲素的微波萃取工艺[J].生物化工,2020,6(04):1-4.
- 24. 陈琪,周静威,孙满强,李世超,周欢欢,李岩.地黄水提物减轻雷公藤甲素所致肝脏氧化应激损伤的实验研究[J].世界中西医结合杂志,2020,15(12):2241-2245+2251.
- 23. 周玉燕, 孙玉, 李萍,等. 莫诺苷通过抗氧化应激保护雷公藤甲素所致肝细胞凋亡[J]. 南方医科大学学报, 2018, 038(008):949-955.
- 22. 臧勇, 田园, 李卫东. 雷公藤甲素通过调节TGF-β1信号通路和Hippo信号通路影响肾小管上皮细胞的上皮-间充质转化[J]. 天津医科大学学报, 2019, 025(003):205-209,224.
- 21. 方妍妍,万磊,董文哲,文建庭,刘健.雷公藤甲素通过调控VEGFA,SDF-1,CXCR4通路改善强直性脊柱炎患者血小板活化的机制[J].中国中药杂志,2019,44(16):3520-3525.
- 20. 王爱利, 王蓓蓓, 罗光伟. 雷公藤甲素通过IL-10/Th17细胞调节哮喘小鼠气道炎症[J]. 内科急危重症杂志, 2019, 25(4).
- 19. 万磊,刘健,黄传兵,张晓军,王亚黎,章平衡,孙玥,刘磊.雷公藤甲素调节佐剂关节炎大鼠滑膜、脾脏、胸腺组织细胞自噬的实验研究[J].四川大学学报(医学版),2017,48(04):520-525.
- 18. 罗国平, 孟会宁, 闫梦茹,等. 雷公藤甲素热敏醇质体的制备工艺[J]. 化工科技, 2020, 028(002):46-51.
- 17. 罗国平, 闫梦茹, 孟会宁,等. 雷公藤甲素普通脂质体与包合物脂质体体外释药特点对比分析[J]. 化工科技, 2020, 028(001):32-36.
- 16. 李文,杨莉莉,王东明,何翔,丁佩军,贺旭锋,边风华,赵晓娴,陈文君,张慧敏.雷公藤甲素对黑色素瘤A375细胞EMT通路及侵袭能力的作用研究[J].上海中医药杂志,2020,54(S1):153-155.
- 15. 李文化, 白雪梅, 吴耀东,等. 雷公藤甲素对早期2型糖尿病大鼠肾脏的保护作用[J]. 河北北方学院学报(自然科学版), 2015, 000(005):77-80.
- 14. 万磊, 刘健, 黄传兵,等. 雷公藤甲素对关节炎大鼠心功能的影响及其作用机制探讨[J]. 四川大学学报(医学版), 2020, v.51(02):82-87.
- 13. 陈宁南, 万强. 雷公藤甲素对PM2.5损伤足细胞的保护作用.
- 12. 陈凯丽, 易剑峰, 翟文静,等. 雷公藤甲素在正常大鼠和佐剂性关节炎模型大鼠体内的药动学研究[J]. 中国药房, 2017, 28(7):923-923.
- 11. 戴媛媛, 高寒, 刘嫦钦,等. 雷公藤多甙对实验性结肠炎大鼠Th17/Treg细胞分化和平衡的影响[J]. 胃肠病学, 2020, v.25(02):26-31.
- 10. 范兆峰, 归小龙, 黄赛杰. 用LC/MS法测定雷公藤甲素纳米乳中雷公藤甲素的含量[J]. 药学服务与研究, 2018, v.18(06):50-53.
- 9. 汪文强, 邓奇, 肖安菊. 湖北黄石野生驯化扦插雷公藤芽、叶中雷公藤甲素的含量分析[J]. 广州中医药大学学报, 2016, 33(006):868-871.
- 8. 郑德杉, 王三亚, 汪文强,等. 样品处理方法对雷公藤叶中雷公藤甲素含量测定结果的影响[J]. 湖北理工学院学报, 2016, 32(004):58-61.
- 7. 周玉燕, 王明艳, 潘学娟,等. 斑蝥酸钠协同雷公藤甲素诱导肝癌细胞株7721凋亡[J]. 中南大学学报(医学版), 2016, 41(9):911-917.
- 6. 黄国东,淮国丽,杨洪吉,王轶,向少伟,覃振林,庞健丽,罗欢,张亚萍,刘振威,许健,吕建珍.复方仙草颗粒对人肾足细胞保护作用的研究[J].北京中医药,2017,36(05):410-415+481.
- 5. 杨盟, 杨帝顺, 顾永卫,等. 基于皮肤,血液双位点同步微透析技术的雷公藤甲素纳米乳体内药动学研究[J]. 中国药学杂志, 2018, 053(011):894-899.
- 4. 李芳琼, 赵东晓, 王娟,等. 基于iTRAQ技术分析不同浓度的雷公藤甲素作用肺癌细胞后的差异蛋白表达[J]. 中国新药杂志, 2018(11).
- 3. 陈琪, 孙满强, 李世超,等. 地黄水提物对雷公藤甲素致肝损伤的减毒作用及抗氧化机制[J]. 上海中医药大学学报, 2020(4):47-52.
- 2. 曾晶 朱龙.响应曲面法优化雷公藤甲素的微波萃取工艺[J].生物化工 2020 6(04):1-4.
- 1. 赵东晓 陈弘磊 孟冠敏 等. 低浓度雷公藤甲素联合顺铂对肝癌细胞HepG2活性的影响[J]. 浙江中西医结合杂志 2017年27卷5期 366-369页 2017.
技术资料文献支持
雷公藤甲素|38748-32-2|Triptolide
¥750 - 2000










